Table 2 Multi-logistic regression analysis against CR by considering following variables: LSC17 score (as a continuous variable), RUNX1 mutation status (mutated vs. wild type), RAS-RTK mutation status (mutated vs. wild type), and ELN high-risk cytogenetics classification (high risk vs. others).

From: Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia

  Estimate Std. error z value P value
LSC17_score −9.71868 4.307062 −2.25645 0.024042
RUNX1 mutation −0.31926 1.016707 −0.31402 0.753508
RAS/RTK mutation 1.64524 1.086779 1.513868 0.130059
ELN high-risk cytogenetics −0.30335 0.945247 −0.32092 0.748271